F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing Boom
A recent FDA advisory committee decision has sparked debate about the expanding peptide market, particularly regarding their distribution th...
Showing all posts with category Peptides
A recent FDA advisory committee decision has sparked debate about the expanding peptide market, particularly regarding their distribution th...
The agency is considering whether compounding pharmacies should be allowed to produce BPC-157, TB-500 and other previously banned peptides.